Clinical Trial Update: A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PF-05089771 alone and as an add-on to pregabalin for painful diabetic neuropathy has completed. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Lyrica (Pregabalin)
• PF-05089771 (PF-05089771)

Snippet

Sponsor: Pfizer | Conditions: Diabetic Neuropathy, Painful | Phase 2 | Status: COMPLETED | Results posted: 2017-05-05